Avadel Pharmaceuticals plc

Ticker AVDL

Exchange NASDAQ More
Industry Drug Manufacturers - Other More
Sector Healthcare More

11-50 Employees
Based in Dublin, Ireland

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is an emerging biopharmaceutical company. The Company’s primary focus is the development and potential FDA approval of FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy.

Visit website

REPORT RATINGS

4.7 / 5.0 (197)

Avadel Pharmaceuticals plc reports have an aggregate usefulness score of 4.7 based on 197 reviews.

Avadel Pharmaceuticals plc